Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ostentus Therapeutics
Ostentus Therapeutics

Ostentus Therapeutics

Seed

Ostentus Therapeutics: A biotech firm innovating in cancer treatment with novel natural compounds.

HQ
Newport Coast, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees

Ostentus Therapeutics, founded with a mission to revolutionize cancer treatment, focuses on studying and developing novel natural compounds. The company's vision is to bring effective and innovative therapies to individuals affected by cancer. Their primary product, OST-01, is at the forefront of their research and development efforts, aiming to offer new hope in oncology. Ostentus Therapeutics targets the biotechnology and pharmaceutical markets, emphasizing cutting-edge cancer therapeutics.

Notable affiliates include a team of experienced management, directors, and advisors who guide the company's strategic direction. Key achievements include significant research milestones and publications in 2023 and 2024, showcasing their progress in cancer treatment innovation. Ostentus Therapeutics has made a substantial impact by advancing the understanding and application of natural compounds in oncology, positioning itself as a promising player in the biotech industry.

Ostentus Therapeutics - Similar Companies

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Starton Therapeutics logo

Starton Therapeutics

Terpenoid Therapeutics logo

Terpenoid Therapeutics

Signet Therapeutics logo

Signet Therapeutics

Virsti Therapeutics logo

Virsti Therapeutics

Grannus Therapeutics logo

Grannus Therapeutics

LTZ Therapeutics logo

LTZ Therapeutics

Kronos Bio logo

Kronos Bio

Outpost Medicine logo

Outpost Medicine

OS Therapies logo

OS Therapies

ostherapies.com

Oncternal Therapeutics logo

Oncternal Therapeutics

oncternal.com

Wave Therapeutics logo

Wave Therapeutics

Pheast Therapeutics logo

Pheast Therapeutics

pheast.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Scorpion Therapeutics logo

Scorpion Therapeutics

Ostentus Therapeutics - Quick Facts

Who are Ostentus Therapeutics' competitors?

Companies similar to Ostentus Therapeutics include OnCusp Therapeutics, Starton Therapeutics, Terpenoid Therapeutics and Signet Therapeutics.

When was Ostentus Therapeutics founded?

Ostentus Therapeutics was founded in 2021.

Where is Ostentus Therapeutics' headquarters located?

Ostentus Therapeutics' headquarters is located in Newport Coast, CA, US.

When was Ostentus Therapeutics' last funding round?

Ostentus Therapeutics' most recent funding round was for $1M (USD) in October 2022.

How much has Ostentus Therapeutics raised to-date?

As of Oct 12, 2022, Ostentus Therapeutics has raised a total of $1.6M (USD).

How many employees does Ostentus Therapeutics have?

Ostentus Therapeutics has 5 employees as of Feb 5, 2024.

Ostentus Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified